💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
| User | Tweets |
|---|---|
| @PetterTrade | 9 |
| @PennySearch | 8 |
| @Tickeron | 8 |
| @Gary_Will120 | 7 |
| @mediasentiment | 6 |
Recent Tweets for ESPR
 |
@PetterTrade $ESPR Waiting for buy signal on ESPR https://t.co/8J1UdYeaX9 January 25th 2022, 4:01pm |
 |
@Tickeron $ESPR's Aroon indicator drops into Downtrend on January 21, 2022. View odds for this and other indicators:… https://t.co/Hk5MZeBACi January 24th 2022, 11:01pm |
 |
@Ba4Saso $ESPR Waiting for Buy signal. Chart by https://t.co/z6vAd7dl0q https://t.co/QLr1p83CV1 January 24th 2022, 5:01pm |
 |
@ShortAlgoKing $ESPR Awaiting Buy Signal. Chart by https://t.co/qchl9O5K2n https://t.co/qq4T4RIrHs January 24th 2022, 11:01am |
 |
@Gary_Will120 RT @Ba4Saso: $ESPR Bullish pattern building. Chart by https://t.co/z6vAd7dl0q https://t.co/enJ1jZQx7B January 24th 2022, 1:01am |
|
@Gary_Will120 RT @SeekingAlpha: $ESPR - Esperion Therapeutics - A Glimmer Of Light At The End Of The Tunnel. https://t.co/Q6L0zVVdNG #stocks #trading #bu… January 24th 2022, 1:01am |
|
@Gary_Will120 RT @PetterTrade: $ESPR Waiting for Buy signal on ESPR https://t.co/YiOtb14Dgu January 24th 2022, 1:01am |
 |
@MaiteMerenda $ESPR Watching for Buy Signal. Chart by https://t.co/t5kOjgsWN3 https://t.co/RtmCPzYSAs January 23rd 2022, 12:01pm |
 |
@Tikenw1Tikenw Worried that $ESPR has managed its earnings. Its average discretionary accruals (the part of accruals that are inde… https://t.co/APBXPWJIqb January 23rd 2022, 7:01am |
 |
@SweepCastApp SweepCast alerted: $ESPR with Unusual Options Activity Alerted on $15 PUT Expiring: 01-21-2022 worth 30K? |? Learn… https://t.co/Z5ktGbdzlY January 23rd 2022, 12:01am |
|
@Gary_Will120 RT @botpicks: Should I Go Long or Short $ESPR ? January 22nd 2022, 3:01pm |
|
@Gary_Will120 RT @Ba4Saso: $ESPR Bullish pattern forming. Chart by https://t.co/z6vAd7dl0q https://t.co/926KAQJPNX January 22nd 2022, 3:01pm |
|
@Gary_Will120 RT @PetterTrade: $ESPR Waiting for Buy signal on ESPR https://t.co/nP6Bdy1Xi6 January 22nd 2022, 3:01pm |
 |
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/VXwRKP9XLQ January 22nd 2022, 4:01am |
 |
@Gambiste1 RT @stockbarnacles: $abos $espr anyone here January 21st 2022, 8:01pm |
 |
@stockbarnacles $abos $espr anyone here January 21st 2022, 8:01pm |
|
@PetterTrade $ESPR Waiting for Buy signal on ESPR https://t.co/nP6Bdy1Xi6 January 21st 2022, 7:01pm |
 |
@newsfilterio Esperion Therapeutics - A Glimmer Of Light At The End Of The Tunnel $ESPR https://t.co/z3QUbjSNx7 January 21st 2022, 6:01pm |
|
@Tickeron $ESPR in +1.21% Uptrend, rising for three consecutive days on January 20, 2022. View odds for this and other indica… https://t.co/JN0W3tKtIH January 21st 2022, 6:01pm |
|
@Tickeron This is amazing! What do you think? $ESPR Aroon Indicator entered a Downtrend. #EsperionTherapeutics #stockmarket… https://t.co/cizZ1OxEB1 January 21st 2022, 5:01pm |
 |
@SeekingAlpha $ESPR - Esperion Therapeutics - A Glimmer Of Light At The End Of The Tunnel. https://t.co/Q6L0zVVdNG #stocks #trading #business January 21st 2022, 1:01pm |
 |
@botpicks Should I Go Long or Short $ESPR ? January 21st 2022, 7:01am |
|
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/2N8GANfpu8 January 21st 2022, 5:01am |
|
@PetterTrade $ESPR Waiting for Buy signal on ESPR https://t.co/YiOtb14Dgu January 20th 2022, 7:01pm |
|
@Ba4Saso $ESPR Bullish pattern forming. Chart by https://t.co/z6vAd7dl0q https://t.co/926KAQJPNX January 20th 2022, 6:01pm |
 |
@alerts_real $ESPR For a limited time, we are opening our trading chatroom to the public https://t.co/MFviwaDMb0 January 20th 2022, 3:01pm |
|
@newsfilterio Esperion Therapeutics: A Potential 'Bio Boom' Or Bust In 2022 $ESPR https://t.co/0neOspmm0A January 20th 2022, 8:01am |
 |
@StckPro $ESPR NEW ARTICLE : Esperion Therapeutics: A Potential 'Bio Boom' Or Bust In 2022 https://t.co/3vnaryIQbk Get all t… https://t.co/WrEVXvMyJZ January 20th 2022, 8:01am |
|
@SeekingAlpha $ESPR - Esperion Therapeutics: A Potential 'Bio Boom' Or Bust In 2022. https://t.co/MaCpiYyejL #stocks #stockmarket #trading January 20th 2022, 8:01am |
 |
@invescent $ESPR Data indicates that the overall analyst sentiment for ESPR is neutral Simplify the way you research stocks… https://t.co/exmJFuy08o January 20th 2022, 4:01am |
|
@Tickeron How does this affect your portfolio? $ESPR RSI Indicator left the oversold zone. #EsperionTherapeutics #stockmarket… https://t.co/Cdn9Bi8hGc January 20th 2022, 3:01am |
|
@PetterTrade $ESPR Waiting for Buy signal on ESPR https://t.co/G7OW0cL4Lc January 19th 2022, 5:01pm |
|
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/pGX4YDxkEW January 19th 2022, 6:01am |
|
@Gary_Will120 $ESPR For a limited time,,, we are opening our trading chatroom to the public, https://t.co/FRMhJx22Xy January 19th 2022, 2:01am |
 |
@LeetsGmbH RT @ihors3: $ESPR short interest is $27M 6.85M shares shorted 11.30 % SI% of Float 10.15 % S3 SI% Float 3.32 % fee Shares shorted down -583… January 18th 2022, 8:01pm |
 |
@ihors3 $ESPR short interest is $27M 6.85M shares shorted 11.30 % SI% of Float 10.15 % S3 SI% Float 3.32 % fee Shares short… https://t.co/LNrSs8H5Eh January 18th 2022, 8:01pm |
|
@Ba4Saso $ESPR Bullish pattern building. Chart by https://t.co/z6vAd7dl0q https://t.co/enJ1jZQx7B January 18th 2022, 7:01pm |
|
@PetterTrade $ESPR Waiting for Buy signal on ESPR https://t.co/5QI8ovZv3W January 18th 2022, 4:01pm |
 |
@shortablestocks $ESPR is short sale restricted for 2022-01-18. https://t.co/dFa4zDe6ej January 18th 2022, 2:01pm |
 |
@mediasentiment $ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 275 January 18th 2022, 6:01am |
|
@invescent $ESPR Data indicates that the overall analyst sentiment for ESPR is bullish. Simplify the way you research stock… https://t.co/S6R7DuNwMp January 18th 2022, 2:01am |
 |
@shilric @MattBiotech other companies should follow the same playbook $ESPR January 17th 2022, 10:01pm |
|
@PetterTrade $ESPR Waiting for Buy signal on ESPR https://t.co/KUI8lFlzZa January 17th 2022, 4:01pm |
|
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/QkcPWli4tQ January 17th 2022, 3:01am |
 |
@MarcJacksonLA $ESPR Esperion Therapeutics Given Average Recommendation of "Hold" by Analysts | $28.30 Average PT… https://t.co/aIeupRyRfQ January 16th 2022, 2:01pm |
|
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/ZY8IodkJuq January 16th 2022, 12:01pm |
 |
@ChartMill Based on estimates for the next 5 years, $ESPR will show a very strong growth in Revenue. https://t.co/GFl1W8bJYJ https://t.co/980AH9TqTz January 16th 2022, 1:01am |
 |
@ShogunTrade $ESPR Awaiting Buy Signal. Free 7 Day Trial at https://t.co/6vnULU2sSf https://t.co/ylFbhwnUVV January 15th 2022, 8:01pm |
|
@PennySearch $ESPR Credit Suisse gave ESPR a Neutral stock rating on 2022-01-14. Find top penny stocks with PennySearch befor… https://t.co/cCv9zuhoib January 15th 2022, 1:01pm |
|
@newsfilterio $ESPR Credit Suisse analyst Judah Frommer maintains Esperion Therapeutics with a Neutral and lowers the price targe… https://t.co/OBaRuTPeMc January 15th 2022, 1:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?